Fielmann Aktiengesellschaft

PINK:FLMNF USA Medical Instruments & Supplies
Market Cap
$3.93 Billion
Market Cap Rank
#7082 Global
#3838 in USA
Share Price
$46.75
Change (1 day)
+0.00%
52-Week Range
$42.54 - $46.75
All Time High
$77.83
About

Fielmann Group AG engages in vision care and audiology business in Germany, Switzerland, Austria, Spain, North America, and internationally. The company manufactures and sells visual aids mainly glasses, eyewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems and its accessories, as well as personal protective equipment. It offers its products under the fielmann, Optik… Read more

Fielmann Aktiengesellschaft (FLMNF) - Total Assets

Latest total assets as of December 2024: $2.37 Billion USD

Based on the latest financial reports, Fielmann Aktiengesellschaft (FLMNF) holds total assets worth $2.37 Billion USD as of December 2024.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Fielmann Aktiengesellschaft - Total Assets Trend (2002–2024)

This chart illustrates how Fielmann Aktiengesellschaft’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Fielmann Aktiengesellschaft - Asset Composition Analysis

Current Asset Composition (December 2024)

Fielmann Aktiengesellschaft's total assets of $2.37 Billion consist of 23.0% current assets and 77.0% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 4.0%
Accounts Receivable $140.19 Million 5.9%
Inventory $259.32 Million 11.0%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $288.46 Million 12.2%
Goodwill $446.91 Million 18.9%

Asset Composition Trend (2002–2024)

This chart illustrates how Fielmann Aktiengesellschaft's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Fielmann Aktiengesellschaft's current assets represent 23.0% of total assets in 2024, a decrease from 46.3% in 2002.
  • Cash Position: Cash and equivalents constituted 4.0% of total assets in 2024, down from 11.1% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, an increase from 11.0% in 2002.
  • Asset Diversification: The largest asset category is goodwill at 18.9% of total assets.

Fielmann Aktiengesellschaft Competitors by Total Assets

Key competitors of Fielmann Aktiengesellschaft based on total assets are shown below.

Company Country Total Assets
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
China CN¥3.82 Billion
Blue Sail Medical Co Ltd
SHE:002382
China CN¥16.46 Billion
Andon Health Co Ltd
SHE:002432
China CN¥28.98 Billion
Allmed Medical Products Co Ltd Class A
SHE:002950
China CN¥5.35 Billion
Inix Technologies Holdings Bhd
KLSE:0094
Malaysia RM72.53 Million
Focus Point Holdings Bhd
KLSE:0157
Malaysia RM328.19 Million
Careplus Group Bhd
KLSE:0163
Malaysia RM286.61 Million
LKL International Bhd
KLSE:0182
Malaysia RM173.46 Million

Fielmann Aktiengesellschaft - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.86 - 1.51

Strong asset utilization - Fielmann Aktiengesellschaft generates 0.96x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: 5.87% - 18.58%

Solid ROA - For every $100 in assets, Fielmann Aktiengesellschaft generates $6.42 in net profit.

Fielmann Aktiengesellschaft - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.64 0.96 1.80
Quick Ratio 0.34 0.54 1.26
Cash Ratio 0.00 0.00 0.00
Working Capital $-301.10 Million $ -19.11 Million $ 234.80 Million

Fielmann Aktiengesellschaft - Advanced Valuation Insights

This section examines the relationship between Fielmann Aktiengesellschaft's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 4.96
Latest Market Cap to Assets Ratio 0.45
Asset Growth Rate (YoY) 19.2%
Total Assets $2.37 Billion
Market Capitalization $1.06 Billion USD

Valuation Analysis

Below Book Valuation: The market values Fielmann Aktiengesellschaft's assets below their book value (0.45 x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Fielmann Aktiengesellschaft's assets grew by 19.2% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Fielmann Aktiengesellschaft (2002–2024)

The table below shows the annual total assets of Fielmann Aktiengesellschaft from 2002 to 2024.

Year Total Assets Change
2024-12-31 $2.37 Billion +19.25%
2023-12-31 $1.99 Billion +12.44%
2022-12-31 $1.77 Billion +1.78%
2021-12-31 $1.74 Billion +3.99%
2020-12-31 $1.67 Billion +22.15%
2019-12-31 $1.37 Billion +44.64%
2018-12-31 $944.79 Million +2.06%
2017-12-31 $925.68 Million +1.33%
2016-12-31 $913.53 Million +2.52%
2015-12-31 $891.11 Million +6.42%
2014-12-31 $837.31 Million +4.74%
2013-12-31 $799.43 Million +6.13%
2012-12-31 $753.23 Million +3.58%
2011-12-31 $727.21 Million +5.38%
2010-12-31 $690.11 Million +4.13%
2009-12-31 $662.73 Million +1.22%
2008-12-31 $654.73 Million +12.57%
2007-12-31 $581.60 Million +9.06%
2006-12-31 $533.27 Million +6.32%
2005-12-31 $501.56 Million +12.29%
2004-12-31 $446.66 Million -16.89%
2003-12-31 $537.42 Million +41.54%
2002-12-31 $379.69 Million --